Environmental lead exposure accelerates progressive diabetic nephropathy in type II diabetic patients

Wen Hung Huang, Ja Liang Lin*, Dan Tzu Lin-Tan, Ching Wei Hsu, Kuan Hsing Chen, Tzung Hai Yen

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

23 Scopus citations

Abstract

Whether environmental lead exposure has a long-term effect on progressive diabetic nephropathy in type II diabetic patients remains unclear. A total of 107 type II diabetic patients with stage 3 diabetic nephropathy (estimated glomerular filtration rate (eGFR) range, 30-60 mL/min/1.73 m2) with normal body lead burden (BLB) (<600 g/72 hr in EDTA mobilization tests) and no history of exposure to lead were prospectively followed for 2 years. Patients were divided into high-normal BLB (>80 g) and low-normal BLB (<80 g) groups. The primary outcome was a 2-fold increase in the initial creatinine levels, long-term dialysis, or death. The secondary outcome was a change in eGFR over time. Forty-five patients reached the primary outcome within 2 years. Although there were no differences in baseline data and renal function, progressive nephropathy was slower in the low-normal BLB group than that in the high-normal BLB group. During the study period, we demonstrated that each 100 g increment in BLB and each 10 g increment in blood lead levels could decrease GFR by 2.2 mL/min/1.72 m2 and 3.0 mL/min/1.72 m2 (P = 0.005), respectively, as estimated by generalized equations. Moreover, BLB was associated with increased risk of achieving primary outcome. Environmental exposure to lead may have a long-term effect on progressive diabetic nephropathy in type II diabetic patients.

Original languageEnglish
Article number742545
JournalBioMed Research International
Volume2013
DOIs
StatePublished - 2013

Fingerprint

Dive into the research topics of 'Environmental lead exposure accelerates progressive diabetic nephropathy in type II diabetic patients'. Together they form a unique fingerprint.

Cite this